These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32138716)

  • 21. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p.
    Zeng Q; Dai Y; Duan C; Zeng R; Zeng Q; Wei C
    BMC Pulm Med; 2020 Jul; 20(1):185. PubMed ID: 32615948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of MAGI2-AS3 in malignant and non-malignant disorders.
    Taheri M; Askari A; Hussen BM; Ghafouri-Fard S; Rashnoo F
    Pathol Res Pract; 2023 Jun; 246():154530. PubMed ID: 37196468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
    Cao C; Zhou S; Hu J
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
    Ren H; Li Z; Tang Z; Li J; Lang X
    J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells.
    Cui S; Liu Z; Tang B; Wang Z; Li B
    BMC Musculoskelet Disord; 2020 Mar; 21(1):149. PubMed ID: 32143617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
    Chang H; Zhang X; Li B; Meng X
    Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
    Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
    Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis.
    Gong J; Ma L; Peng C; Liu J
    Ann Transl Med; 2021 Dec; 9(24):1793. PubMed ID: 35071487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
    Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
    Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.
    Lei L; Huang Y; Gong W
    Mol Cell Biochem; 2014 Feb; 387(1-2):171-6. PubMed ID: 24162673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
    Dong Z; Hu B; Wang S; Wang M; Sun S; Liu X; Li D; Wu D
    J Orthop Surg Res; 2024 Jun; 19(1):370. PubMed ID: 38907263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
    Xu X; Yuan X; Ni J; Guo J; Gao Y; Yin W; Li F; Wei L; Zhang J
    J Cell Physiol; 2021 Feb; 236(2):1116-1130. PubMed ID: 32730644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
    Shen D; Xu J; Cao X; Cao X; Tan H; Deng H
    Cancer Biomark; 2021; 30(2):155-165. PubMed ID: 33104021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
    Chen Z; Zhou J; Liu Y; Ni H; Zhou B
    Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel insights for lncRNA MAGI2-AS3 in solid tumors.
    Xue C; Li G; Lu J; Luo J; Jia J
    Biomed Pharmacother; 2021 May; 137():111429. PubMed ID: 33761624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of lncRNA MAGI2-AS3 in human cancers.
    Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
    Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
    Wang G; Li H; Hou Y
    Cancer Gene Ther; 2022 May; 29(5):585-596. PubMed ID: 34002044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA HOXC-AS3 overexpression inhibits TGF-β2-induced colorectal cancer cell migration and invasion by sponging miR-1269.
    Zhang TT; Chen HP; Yu SY; Zhao SP
    Hum Exp Toxicol; 2022; 41():9603271221093630. PubMed ID: 35537198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a.
    Huang S; Li C; Huang J; Luo P; Mo D; Wang H
    BMC Pulm Med; 2020 Apr; 20(1):110. PubMed ID: 32349744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.